Cargando…

Drug Inhibition of Redox Factor-1 Restores Hypoxia-Driven Changes in Tuberous Sclerosis Complex 2 Deficient Cells

SIMPLE SUMMARY: Tuberous sclerosis complex (TSC) is a genetic disease where patients are predisposed to tumors and neurological complications. Current therapies for this disease are not fully curative. We aimed to explore novel drug targets and therapies that could further benefit TSC patients. This...

Descripción completa

Detalles Bibliográficos
Autores principales:	Champion, Jesse D., Dodd, Kayleigh M., Lam, Hilaire C., Alzahrani, Mohammad A. M., Seifan, Sara, Rad, Ellie, Scourfield, David Oliver, Fishel, Melissa L., Calver, Brian L., Ager, Ann, Henske, Elizabeth P., Davies, David Mark, Kelley, Mark R., Tee, Andrew R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776744/ https://www.ncbi.nlm.nih.gov/pubmed/36551683 http://dx.doi.org/10.3390/cancers14246195

Ejemplares similares

RelA Is an Essential Target for Enhancing Cellular Responses to the DNA Repair/Ref-1 Redox Signaling Protein and Restoring Perturbated Cellular Redox Homeostasis in Mouse PDAC Cells
por: Mijit, Mahmut, et al.
Publicado: (2022)

APE1/Ref-1 redox-specific inhibition decreases survivin protein levels and induces cell cycle arrest in prostate cancer cells
por: McIlwain, David W., et al.
Publicado: (2017)

Vps34-mediated macropinocytosis in Tuberous Sclerosis Complex 2-deficient cells supports tumorigenesis
por: Filippakis, Harilaos, et al.
Publicado: (2018)

Spectrum of germline and somatic mitochondrial DNA variants in Tuberous Sclerosis Complex
por: Giannikou, Krinio, et al.
Publicado: (2023)

Renal Cell Carcinoma in Tuberous Sclerosis Complex
por: Henske, Elizabeth P., et al.
Publicado: (2021)

Non-canonical functions of the tuberous sclerosis complex-Rheb signalling axis
por: Neuman, Nicole A, et al.
Publicado: (2011)

Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours
por: Gampala, Silpa, et al.
Publicado: (2021)

Correction: Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours
por: Gampala, Silpa, et al.
Publicado: (2022)

Regulation of YAP by mTOR and autophagy reveals a therapeutic target of tuberous sclerosis complex
por: Liang, Ning, et al.
Publicado: (2014)

Evaluation of copy number variation and gene expression in neurofibromatosis type-1-associated malignant peripheral nerve sheath tumours
por: Thomas, Laura E, et al.
Publicado: (2015)

Correction: Loss of tuberous sclerosis complex 2 sensitizes tumors to nelfinavir–bortezomib therapy to intensify endoplasmic reticulum stress-induced cell death
por: Johnson, Charlotte E., et al.
Publicado: (2019)

STAT3 and mTOR: co-operating to drive HIF and angiogenesis
por: Dodd, Kayleigh M., et al.
Publicado: (2015)

MicroRNA-21 is Induced by Rapamycin in a Model of Tuberous Sclerosis (TSC) and Lymphangioleiomyomatosis (LAM)
por: Trindade, Anil J., et al.
Publicado: (2013)

Cultivar-dependent differences in tuber growth cause increased soil resistance in potato fields
por: Skilleter, Patrick, et al.
Publicado: (2023)

Real-Time Monitoring of Tumorigenesis, Dissemination, & Drug Response in a Preclinical Model of Lymphangioleiomyomatosis/Tuberous Sclerosis Complex
por: Liu, Fangbing, et al.
Publicado: (2012)

Kidney intercalated cells and the transcription factor FOXi1 drive cystogenesis in tuberous sclerosis complex
por: Barone, Sharon, et al.
Publicado: (2021)

The tuberous sclerosis proteins regulate formation of the primary cilium via a rapamycin-insensitive and polycystin 1-independent pathway
por: Hartman, Tiffiney R., et al.
Publicado: (2009)

Lysosomal regulation of cholesterol homeostasis in tuberous sclerosis complex is mediated via NPC1 and LDL-R
por: Filippakis, Harilaos, et al.
Publicado: (2017)

Serum endostatin levels are associated with diffusion capacity and with tuberous sclerosis- associated lymphangioleiomyomatosis
por: Lamattina, Anthony M., et al.
Publicado: (2019)

Symmetry and range limits in importance indices
por: Seifan, Tal, et al.
Publicado: (2015)

Oncogenic Signalling through Mechanistic Target of Rapamycin (mTOR): A Driver of Metabolic Transformation and Cancer Progression
por: Rad, Ellie, et al.
Publicado: (2018)

Ref-1 redox activity alters cancer cell metabolism in pancreatic cancer: exploiting this novel finding as a potential target
por: Gampala, Silpa, et al.
Publicado: (2021)

Reciprocal effects of mTOR inhibitors on pro-survival proteins dictate therapeutic responses in tuberous sclerosis complex
por: McNamara, Molly C., et al.
Publicado: (2022)

All tubers are not created equal: Cerebellar tubers in a pediatric patient with tuberous sclerosis
por: Weerasinghe, Sanjeeva, et al.
Publicado: (2020)

Energy Stress-Mediated Cytotoxicity in Tuberous Sclerosis Complex 2-Deficient Cells with Nelfinavir and Mefloquine Treatment
por: McCann, Henry D., et al.
Publicado: (2018)

APE1/Ref-1 – One Target with Multiple Indications: Emerging Aspects and New Directions
por: Mijit, Mahmut, et al.
Publicado: (2021)

Redox state affects fecundity and insecticide susceptibility in Anopheles gambiae
por: Champion, Cody J., et al.
Publicado: (2018)

Epileptogenic but MRI-normal perituberal tissue in Tuberous Sclerosis Complex contains tuber-specific abnormalities
por: Sosunov, Alexander A, et al.
Publicado: (2015)

Tubers and Tumors Are CLIPped Together in Tuberous Sclerosis Complex
por: Dang, Louis
Publicado: (2022)

PEBP Signaling Network in Tubers and Tuberous Root Crops
por: Susila, Hendry, et al.
Publicado: (2023)

Bergenin Reduces Experimental Painful Diabetic Neuropathy by Restoring Redox and Immune Homeostasis in the Nervous System
por: Villarreal, Cristiane F., et al.
Publicado: (2020)

APE1/Ref‐1 knockdown in pancreatic ductal adenocarcinoma – characterizing gene expression changes and identifying novel pathways using single‐cell RNA sequencing
por: Shah, Fenil, et al.
Publicado: (2017)

Anakinra restores cellular proteostasis by coupling mitochondrial redox balance to autophagy
por: van de Veerdonk, Frank L., et al.
Publicado: (2022)

Novel Histopathological Patterns in Cortical Tubers of Epilepsy Surgery Patients with Tuberous Sclerosis Complex
por: Mühlebner, Angelika, et al.
Publicado: (2016)

Tuberous sclerosis
por: George, Anisha, et al.
Publicado: (2015)

Exploiting the Ref-1-APE1 node in cancer signaling and other diseases: from bench to clinic
por: Shah, Fenil, et al.
Publicado: (2017)

Protease activity sensors enable real-time treatment response monitoring in lymphangioleiomyomatosis
por: Kirkpatrick, Jesse D., et al.
Publicado: (2022)

The Neurodevelopmental Pathogenesis of Tuberous Sclerosis Complex (TSC)
por: Feliciano, David M.
Publicado: (2020)

Myelin Pathology Beyond White Matter in Tuberous Sclerosis Complex (TSC) Cortical Tubers
por: Mühlebner, Angelika, et al.
Publicado: (2020)

Seizure Localization in Patients with Multiple Tubers: Presurgical Evaluation in Tuberous Sclerosis
por: Song, Pamela, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_v9a0ho1l38dhf1b6dh8l6hajr6